Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%2522COVID-19%2522&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%2522COVID-19%2522&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%2522COVID-19%2522&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (12)
1
Burden and sequelae of influenza and SARSCoV-2 among adults a multisite study in India : Burden and sequelae of influenza, SARSCo-V2 and other respiratory viruses associated Severe Acute Respiratory Infections among adult Indian Population aged 18-60 years
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Burden and sequelae of influenza and SARSCoV-2 among adults a multisite study in India : Burden and sequelae of influenza, SARSCo-V2 and other respiratory viruses associated Severe Acute Respiratory Infections among adult Indian Population aged 18-60 years
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Investigation of clinical characteristics, management and outcome of ARDS patients: a Germany-wide register study DIVI ECMO COVID-19 Register : Investigation of clinical characteristics, management and outcome of ARDS patients: a Germany-wide register study DIVI ECMO COVID-19 Register - DIVI ECMO COVID Register
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
4
Investigation of clinical characteristics, management and outcome of ARDS patients: a Germany-wide register study DIVI ECMO COVID-19 Register : Investigation of clinical characteristics, management and outcome of ARDS patients: a Germany-wide register study DIVI ECMO COVID-19 Register - DIVI ECMO COVID Register
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
5
ravulizumab for the treatment of patients with Coronavirus Disease 2019 : A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome - -
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
6
ravulizumab for the treatment of patients with Coronavirus Disease 2019 : A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome - -
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
7
The OVID study will show whether prophylactic-dose enoxaparin improves survival and reduces any hospitalizations in ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation : ENOXAPARIN FOR PRIMARY THROMBOPROPHYLAXIS IN AMBULATORY PATIENTS WITH CORONAVIRUS: THE MULTICENTER RANDOMIZED CONTROLLED OVID TRIAL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
8
The OVID study will show whether prophylactic-dose enoxaparin improves survival and reduces any hospitalizations in ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and coagulation activation : ENOXAPARIN FOR PRIMARY THROMBOPROPHYLAXIS IN AMBULATORY PATIENTS WITH CORONAVIRUS: THE MULTICENTER RANDOMIZED CONTROLLED OVID TRIAL
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
9
Nebulised heparin in COVID-19-related ARDS patients undergoing helmet non-invasive ventilation : Nebulised heparin in COVID-19-related ARDS patients undergoing non-invasive ventilation with helmet cPAP: a prospective, randomised, double blind, placebo-controlled, multicentre study - HelmetHeparin
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
10
Nebulised heparin in COVID-19-related ARDS patients undergoing helmet non-invasive ventilation : Nebulised heparin in COVID-19-related ARDS patients undergoing non-invasive ventilation with helmet cPAP: a prospective, randomised, double blind, placebo-controlled, multicentre study - HelmetHeparin
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
12
Aufsätze
12
E-Artikel
12
E-Ressourcen
Zeitschriftentitel
12
WHO International Clinical Trials Registry Plat...
Thema
12
610
8
Study Type: Interventional
6
Recruitment Status: Not yet recruiting
4
Phase: Phase 2
4
Phase: Phase 3
4
Recruitment Status: Authorised-recruitment may ...
4
Study Type: Observational
2
Medical Condition: COVID-19 induced ARDS # Inte...
2
Medical Condition: COVID-19 severe pneumonia, a...
2
Medical Condition: COVID-19-related Acute Respi...
2
Medical Condition: Health Condition 1: U071- CO...
2
Medical Condition: Patients diagnosed with COVI...
2
Medical Condition: Patients with COVID-19 infec...
2
Recruitment Status: Recruiting
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2023
8
2022
2
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
12
Englisch
Haven't found what you're looking for?
Wird geladen...